Pharmaceutical companies are accelerating M&A and licensing activity to rebuild pipelines—but realizing value from these deals depends on how quickly and effectively regulatory content can be integrated.
In this session, we will share how regulatory content migration has become the critical path to post-acquisition success, and how leading organizations are leveraging automation and scalable delivery models to accelerate integration while maintaining compliance.
Why regulatory content migration has become a critical path in pharma M&A integration
The common challenges across legacy systems, content, data, and global regulatory requirements
How evolving standards such as eCTD 4.0 and IDMP are shaping migration strategies
How automation and AI can improve migration speed, quality, and scalability
Practical approaches for building a more efficient, lower-risk migration model
Space is limited. Secure your spot today.
Founded in 1976, CGI is among the largest IT and business consulting services firms in the world. We are insights-driven and outcomes-based to help accelerate returns on your investments.